Walid F Gellad1, Jennifer S Haas, Dana Gelb Safran. 1. Division of General Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120-1613, USA.
Abstract
BACKGROUND: Nonadherence to prescription drugs results in poorer control of chronic health conditions. Because of significant racial/ethnic disparities in the control of many chronic diseases, differences in the rates of and reasons for medication nonadherence should be studied. OBJECTIVES: 1) To determine whether rates of and reasons for medication nonadherence vary by race/ethnicity among seniors; and 2) to evaluate whether any association between race/ethnicity and nonadherence is moderated by prescription coverage and income. DESIGN/ SETTING: Cross-sectional national survey, 2003. PATIENTS: Medicare beneficiaries > or = 65 years of age, who reported their race/ethnicity as white, black, or Hispanic, and who reported taking at least 1 medication (n = 14,829). MAIN OUTCOME MEASURES: Self-reported nonadherence (caused by cost, self-assessed need, or experiences/side effects) during the last 12 months. RESULTS: Blacks and Hispanics were more likely than whites to report cost-related nonadherence (35.1%, 36.5%, and 26.7%, respectively, p < .001). There were no racial/ethnic differences in nonadherence caused by experiences or self-assessed need. In analyses controlling for age, gender, number of chronic conditions and medications, education, and presence and type of prescription drug coverage, blacks (odds ratio [OR] 1.38; 95% confidence interval [CI] 1.08-1.78) and Hispanics (1.35; 1.02-1.78) remained more likely to report cost-related nonadherence compared to whites. When income was added to the model, the relationship between cost-related nonadherence and race/ethnicity was no longer statistically significant (p = .12). CONCLUSIONS: Racial/ethnic disparities in medication nonadherence exist among seniors, and are related to cost concerns, and not to differences in experiences or self-assessed need. Considering the importance of medication adherence in controlling chronic diseases, affordability of prescriptions should be explicitly addressed to reduce racial/ethnic disparities.
BACKGROUND: Nonadherence to prescription drugs results in poorer control of chronic health conditions. Because of significant racial/ethnic disparities in the control of many chronic diseases, differences in the rates of and reasons for medication nonadherence should be studied. OBJECTIVES: 1) To determine whether rates of and reasons for medication nonadherence vary by race/ethnicity among seniors; and 2) to evaluate whether any association between race/ethnicity and nonadherence is moderated by prescription coverage and income. DESIGN/ SETTING: Cross-sectional national survey, 2003. PATIENTS: Medicare beneficiaries > or = 65 years of age, who reported their race/ethnicity as white, black, or Hispanic, and who reported taking at least 1 medication (n = 14,829). MAIN OUTCOME MEASURES: Self-reported nonadherence (caused by cost, self-assessed need, or experiences/side effects) during the last 12 months. RESULTS: Blacks and Hispanics were more likely than whites to report cost-related nonadherence (35.1%, 36.5%, and 26.7%, respectively, p < .001). There were no racial/ethnic differences in nonadherence caused by experiences or self-assessed need. In analyses controlling for age, gender, number of chronic conditions and medications, education, and presence and type of prescription drug coverage, blacks (odds ratio [OR] 1.38; 95% confidence interval [CI] 1.08-1.78) and Hispanics (1.35; 1.02-1.78) remained more likely to report cost-related nonadherence compared to whites. When income was added to the model, the relationship between cost-related nonadherence and race/ethnicity was no longer statistically significant (p = .12). CONCLUSIONS: Racial/ethnic disparities in medication nonadherence exist among seniors, and are related to cost concerns, and not to differences in experiences or self-assessed need. Considering the importance of medication adherence in controlling chronic diseases, affordability of prescriptions should be explicitly addressed to reduce racial/ethnic disparities.
Authors: Dana Gelb Safran; Patricia Neuman; Cathy Schoen; Michelle S Kitchman; Ira B Wilson; Barbara Cooper; Angela Li; Hong Chang; William H Rogers Journal: Health Aff (Millwood) Date: 2005 Jan-Jun Impact factor: 6.301
Authors: Stephen B Soumerai; Marsha Pierre-Jacques; Fang Zhang; Dennis Ross-Degnan; Alyce S Adams; Jerry Gurwitz; Gerald Adler; Dana Gelb Safran Journal: Arch Intern Med Date: 2006-09-25
Authors: John Hsu; Mary Price; Jie Huang; Richard Brand; Vicki Fung; Rita Hui; Bruce Fireman; Joseph P Newhouse; Joseph V Selby Journal: N Engl J Med Date: 2006-06-01 Impact factor: 91.245
Authors: P Michael Ho; John S Rumsfeld; Frederick A Masoudi; David L McClure; Mary E Plomondon; John F Steiner; David J Magid Journal: Arch Intern Med Date: 2006-09-25
Authors: Gabriel S Tajeu; Shia T Kent; Ian M Kronish; Lei Huang; Marie Krousel-Wood; Adam P Bress; Daichi Shimbo; Paul Muntner Journal: Hypertension Date: 2016-07-18 Impact factor: 10.190
Authors: Geoffrey C Nguyen; Thomas A LaVeist; Mary L Harris; Lisa W Datta; Theodore M Bayless; Steven R Brant Journal: Inflamm Bowel Dis Date: 2009-08 Impact factor: 5.325
Authors: Joseph T Hanlon; Robert M Boudreau; Subashan Perera; Elsa S Strotmeyer; Anne B Newman; Eleanor M Simonsick; Ronald I Shorr; Douglas C Bauer; Julie M Donohue Journal: Am Heart J Date: 2013-08-28 Impact factor: 4.749
Authors: Claudia M Lora; Alexander W Sokolovsky; Daniel R Touchette; Jing Jin; Xiaojing Hu; Weihua Gao; Ben S Gerber Journal: Ethn Dis Date: 2013 Impact factor: 1.847